<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cai J</submitter><funding>Intramural NIH HHS</funding><funding>National Natural Science Foundation of China</funding><funding>National Cancer Institute</funding><pagination>e21496</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9813681</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>35(5)</volume><pubmed_abstract>Saururus chinensis (S chinensis) has been used as an herb to treat edema, jaundice, and gonorrhea. Manassantin B (MNSB), a dineolignan isolated from S chinensis, was identified as a potent adipogenesis/lipogenesis inhibitor (IC&lt;sub>50&lt;/sub>  = 9.3 nM). To explore the underlying mechanism, both adipogenesis and lipogenesis were measured in differentiated 3T3-L1 preadipocytes, murine primary preadipocytes and adipose tissue explants upon MNSB treatment. Key regulators of adipogenesis/lipogenesis were downregulated by MNSB treatment, mainly resulting from increased phosphorylation of AMPK which was identified as a vital regulator of adipogenesis and lipogenesis. Moreover, MNSB did not increase AMPK phosphorylation in 3T3-L1 cells transfected with Prkaa1 (encoding protein kinase AMP-activated </pubmed_abstract><journal>FASEB journal : official publication of the Federation of American Societies for Experimental Biology</journal><pubmed_title>Manassantin B attenuates obesity by inhibiting adipogenesis and lipogenesis in an AMPK dependent manner.</pubmed_title><pmcid>PMC9813681</pmcid><funding_grant_id>81573310</funding_grant_id><funding_grant_id>ZIA BC005708</funding_grant_id><pubmed_authors>Sun L</pubmed_authors><pubmed_authors>Yuan S</pubmed_authors><pubmed_authors>Qiong G</pubmed_authors><pubmed_authors>Li C</pubmed_authors><pubmed_authors>Cai J</pubmed_authors><pubmed_authors>Luo Y</pubmed_authors><pubmed_authors>Gonzalez FJ</pubmed_authors><pubmed_authors>Xu J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Manassantin B attenuates obesity by inhibiting adipogenesis and lipogenesis in an AMPK dependent manner.</name><description>Saururus chinensis (S chinensis) has been used as an herb to treat edema, jaundice, and gonorrhea. Manassantin B (MNSB), a dineolignan isolated from S chinensis, was identified as a potent adipogenesis/lipogenesis inhibitor (IC&lt;sub>50&lt;/sub>  = 9.3 nM). To explore the underlying mechanism, both adipogenesis and lipogenesis were measured in differentiated 3T3-L1 preadipocytes, murine primary preadipocytes and adipose tissue explants upon MNSB treatment. Key regulators of adipogenesis/lipogenesis were downregulated by MNSB treatment, mainly resulting from increased phosphorylation of AMPK which was identified as a vital regulator of adipogenesis and lipogenesis. Moreover, MNSB did not increase AMPK phosphorylation in 3T3-L1 cells transfected with Prkaa1 (encoding protein kinase AMP-activated </description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 May</publication><modification>2025-04-04T13:52:56.822Z</modification><creation>2025-04-04T13:52:56.822Z</creation></dates><accession>S-EPMC9813681</accession><cross_references><pubmed>33904622</pubmed><doi>10.1096/fj.202002126RR</doi><doi>10.1096/fj.202002126rr</doi></cross_references></HashMap>